Add-on Acquisition • Life Science

Hovione Acquires ExtremoChem

On November 16, 2023, Hovione acquired life science company ExtremoChem

Acquisition Context

This is Hovione’s 1st transaction in the Life Science sector.
This is Hovione’s 1st transaction in Portugal.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 16, 2023
Target	ExtremoChem
Sector	Life Science
Buyer(s)	Hovione
Deal Type	Add-on Acquisition

Target Company

ExtremoChem

Lisboa, Portugal

ExtremoChem is a chemical synthesis company focused on the development of organic synthetic sugars for the stabilization of biologicals under stress conditions. ExtremoChem is based in Lisbon, Portugal.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Hovione

Loures, Portugal

Category	Company
Founded	1959
Sector	Life Science

DESCRIPTION

Hovione is a contract development and manufacturing organization (CDMO) offering fully integrated services for drug substances, intermediates, and drug products. It supports pharmaceutical clients with the development and compliant manufacture of innovative and highly potent drugs, delivering customized solutions across the entire drug life cycle. Hovione was founded in 1959 and is based in Loures, Portugal.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Portugal	1 of 1
Year: 2023	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Portugal M&A - 2023 M&A